X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (44) 44
humans (40) 40
previously untreated patients (20) 20
oncology (16) 16
female (14) 14
cancer (12) 12
hematology (12) 12
care and treatment (10) 10
pharmacology & pharmacy (10) 10
previously treated patients (10) 10
middle aged (9) 9
adult (8) 8
male (8) 8
aged (7) 7
animals (7) 7
health aspects (7) 7
medicine & public health (7) 7
open-label (7) 7
surgery (7) 7
treatment outcome (7) 7
antineoplastic agents - therapeutic use (6) 6
non-hodgkins-lymphoma (6) 6
phase-ii trial (6) 6
review (6) 6
antibodies, monoclonal - therapeutic use (5) 5
cell lung-cancer (5) 5
chemotherapy (5) 5
chronic lymphocytic leukemia (5) 5
clinical trials as topic (5) 5
egfr (5) 5
prognosis (5) 5
activated factor-vii (4) 4
bone-marrow-transplantation (4) 4
breast neoplasms - surgery (4) 4
chronic lymphocytic-leukemia (4) 4
drug therapy (4) 4
factor-ix inhibitors (4) 4
gefitinib (4) 4
high-dose chemotherapy (4) 4
immune tolerance (4) 4
leukemia (4) 4
mammaplasty (4) 4
neoplasms - drug therapy (4) 4
pharmacology/toxicology (4) 4
pharmacotherapy (4) 4
receptor, epidermal growth factor - antagonists & inhibitors (4) 4
receptor, epidermal growth factor - metabolism (4) 4
rituximab (4) 4
acute hemarthroses (3) 3
acute lymphoblastic-leukemia (3) 3
acute myeloid-leukemia (3) 3
antibodies (3) 3
antineoplastic agents - administration & dosage (3) 3
biomedicine (3) 3
biotechnology & applied microbiology (3) 3
bleeding episodes (3) 3
breast implants (3) 3
breast reconstruction (3) 3
cancer research (3) 3
clinical neurology (3) 3
colony-stimulating factor (3) 3
conservation therapy (3) 3
epidermal growth factor (3) 3
erlotinib (3) 3
factor viii - immunology (3) 3
fludarabine (3) 3
hematology, oncology and palliative medicine (3) 3
hemophilia a - drug therapy (3) 3
hemophilia a - immunology (3) 3
hemophilia-a patients (3) 3
heterocyclic compounds - therapeutic use (3) 3
immunology (3) 3
internal medicine (3) 3
leukemia - therapy (3) 3
leukemia, lymphocytic, chronic, b-cell - drug therapy (3) 3
lymphoma (3) 3
mammaplasty - methods (3) 3
mastectomy (3) 3
medical research (3) 3
minimal residual disease (3) 3
monoclonal-antibody (3) 3
multicenter (3) 3
mutation (3) 3
physiological aspects (3) 3
plus g-csf (3) 3
previously failing mobilization (3) 3
previously untrained women (3) 3
randomized-trial (3) 3
relapsed (3) 3
research (3) 3
respiratory system (3) 3
retrospective studies (3) 3
risk factors (3) 3
southwest-oncology-group (3) 3
stem cells (3) 3
time factors (3) 3
tyrosine kinase inhibitor (3) 3
1st-line treatment (2) 2
2nd-line treatment (2) 2
abridged index medicus (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Plastic, Reconstructive & Aesthetic Surgery, ISSN 1748-6815, 2015, Volume 68, Issue 4, pp. e71 - e79
Summary Background Millions of women have undergone augmentation mammaplasty with implants and breast cancer continuing to be the most common non-cutaneous... 
Plastic Surgery | Prior augmented | Capsular contracture | Breast reconstruction | Previously augmented | Breast implants | SURGERY | SPARING MASTECTOMY | MAMMAPLASTY | CANCER | Breast Neoplasms - surgery | Reoperation | Humans | Middle Aged | Mammaplasty - methods | Female | Retrospective Studies | Breast Implants | Postoperative Complications | Women | Health aspects | Mammaplasty | Index Medicus
Journal Article
Plastic and Reconstructive Surgery, ISSN 0032-1052, 03/2007, Volume 119, Issue 3, pp. 775 - 785
Journal Article
Annals of Plastic Surgery, ISSN 0148-7043, 03/2017, Volume 78, Issue 6, pp. S269 - S274
Journal Article
Journal of Cardiac Failure, ISSN 1071-9164, 2011, Volume 17, Issue 11, pp. 899 - 906
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 10/2017, Volume 58, Issue 10, pp. 2287 - 2297
The recent development of small molecule inhibitors targeted at the B-cell receptor (BCR) pathway and the anti-apoptotic protein BCL-2 has revolutionized the... 
ibrutinib | BCL-2 | combination therapy | Chronic lymphocytic leukemia | venetoclax | FOLLOW-UP | PHASE-II | OPEN-LABEL | KAPPA-B | PREVIOUSLY UNTREATED PATIENTS | SINGLE-AGENT IBRUTINIB | BRUTONS TYROSINE KINASE | TARGETING BCL2 | ONCOLOGY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | Index Medicus
Journal Article
EXPERT REVIEW OF HEMATOLOGY, ISSN 1747-4086, 02/2019, Volume 12, Issue 2, pp. 89 - 98
Introduction: Several recurrently deregulated pathways implicated in the development of chronic lymphocytic leukemia (CLL) have been described over the last... 
Biomarker | FREE SURVIVAL | TP53 MUTATION | CLONAL EVOLUTION | OPEN-LABEL | PROGNOSTIC SUBGROUPS | SF3B1 MUTATIONS | novel agents | PREVIOUSLY UNTREATED PATIENTS | chronic lymphocytic leukemia | B-CELL LYMPHOCYTOSIS | NOTCH1 MUTATIONS | HEMATOLOGY | DISEASE PROGRESSION
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2004, Volume 94, Issue 2, pp. 352 - 362
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 11/2006, Volume 58, Issue S1, pp. 33 - 37
Although the initial impact of the epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) gefitinib may have been less than spectacular in the... 
EGFR mutation | Biomedicine | Erlotinib | Oncology | Cancer Research | EGFR-TKI | Pharmacology/Toxicology | Gefitinib | CARBOPLATIN | erlotinib | gefitinib | COMBINATION | PACLITAXEL | CELL LUNG-CANCER | PHASE-III TRIAL | IRESSA | ONCOLOGY | PHARMACOLOGY & PHARMACY | MUTATIONS | PREVIOUSLY TREATED PATIENTS | Care and treatment | Cancer
Journal Article
Journal Article